Bifidobacterium Infantis M-63
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bifidobacterium Infantis M-63, covering 2017-10-24 to 2017-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster [Phase 2, Phase 3]